The current study aims to determine whether prostate stem cell antigen (PSCA) gene polymorphism confers a risk for hepatocellular carcinoma (HCC).
The aim is to find out the novel markers for predicting HCC risk and provide an early warning mechanism for the population susceptible to HCC.
